Loading company…
Spruce Medimaging provides independent imaging evaluation services for clinical research.
Founded in Beijing in 2022, Spruce Medimaging provides independent imaging evaluation for innovative drug clinical research. Its services cover CT, MRI and X-ray assessments for medical institutions, pharmaceutical and medical device companies. The company raised Series A funding in August 2024 to upgrade its assessment systems, expand its team and develop its market.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in